section name header

Evidence summaries

Short Acting Beta Agonists for Recurrent Wheeze in Children Under 2 Years of Age

Short acting beta agonists may have limited effect on the symptoms of infants with recurrent wheeze. Level of evidence: "C"

A Cochrane review [Abstract] 1 included 8 studies with a total of 229 patients. Improvement in respiratory rate, symptom score and oxygen saturation were noted in one study in the emergency department following two salbutamol nebulisers but this had no impact on hospital admission. There was a reduction in bronchial reactivity following salbutamol. There was no significant benefit from taking regular inhaled salbutamol on symptom scores recorded at home.

Comment: The quality of evidence is downgraded by inconsistency (heterogeneity in results in different populations) and sparse data.

    References

    • Chavasse R, Seddon P, Bara A, McKean M. Short acting beta agonists for recurrent wheeze in children under 2 years of age. Cochrane Database Syst Rev 2002;(3):CD002873. [PubMed]

Primary/Secondary Keywords